Expression of tissue factor pathway inhibitor-2 in murine and human liver regulation during inflammation

Thrombosis and Haemostasis

Volumn 91, Issue 3, 2004, Pages 569-575

  Hisaka, Toru ^a   Lardeux, Bernard ^a   Lamrieau, Thierry ^a   Wüestefeld, Torsten ^b   Lalor, Patricia F ^c   Neaud, Véronique ^a   Maurel, Patrick ^d   Desmoulière, Alexis ^a   Kisiel, Walter ^e   Trautwein, Christian ^b   Rosenbaum, Jean ^a  

^a INSERM   (France)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d CNRS   (France)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Extracellular matrix; Inflammatory mediators; Proteases inhibitors; Tissue factor pathway inhibitor (TFPI)

Indexed keywords

ACUTE PHASE PROTEIN; CELL RECEPTOR; GLYCOPROTEIN GP 130; LIPOPOLYSACCHARIDE; MESSENGER RNA; OROSOMUCOID; PLACENTA PROTEIN 5;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFLAMMATION; KINETICS; LIVER; LIVER CELL; LIVER PARENCHYMA; LIVER SINUSOID; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; UPREGULATION;

EID: 12144288140     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-06-0358     Document Type: Article

References (33)

1. Kisiel W, Sprecher CA, Foster DC. Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent. Blood 1994; 84: 4384-5.
2. Petersen LC, Sprecher CA, Foster DC, et al.. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 1996; 35: 266-72.
3. Miyagi Y, Yasumitsu H, Mizushima, H, et al.. Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6. DNA Cell Biol 1996; 15: 947-54.
4. Sprecher CA, Kisiel W, Mathewes S, et al.. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci USA 1994; 91: 3353-7.
5. Streetz KL, Wustefeld T, Klein C, et al.. Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 2003; 125: 532-43.
6. Betz UA, Bloch W, van den Broek M, et al.. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med 1998; 188: 1955-65.
7. Kellendonk C, Opherk C, Anlag K, et al.. Hepatocyte-specific expression of Cre recombinase. Genesis 2000; 26: 151-3.
8. Klaunig JE, Goldblatt PJ, Hinton DE, et al.. Mouse Ever cell culture. I. Hepatocyte isolation. In Vitro 1981; 17: 913-25.
9. Ferrini JB, Pichard L, Domergue J, et al.. Long-term primary cultures of adult human hepatocytes. Chem Biol Interact 1997; 107: 31-45.
10. Lalor PF, Edwards S, McNab G, et al.. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol 2002; 169: 983-92.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
12. Puissant C, Houdebine LM. An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Biotechniques 1990; 8: 148-9.
13. Fort P, Marty L, Piechaczyk M, et al.. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 1985; 13: 1431-42.
14. Kaabache T, Barraud B, Feldmann G, et al.. Direct solution hybridization of guanidine thiocyanate-solubilized cells for quantitation of mRNAs in hepatocytes. Anal Biochem 1995; 232: 225-30.
15. Blazejewski S, Le Bail B, Boussarie L, et al.. Osteonectin (SPARC) expression in human liver and in cultured human liver myofibro-blasts. Am J Pathol 1997; 151: 651-7.
16. Faouzi S, Le Bail B, Neaud V, et al.. Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: An in vivo and in vitro study. J Hepatol 1999; 30: 275-84.
17. Neaud V, Hisaka T, Monvoisin A, et al.. Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J Biol Chem 2000; 275: 35565-9.
18. Neaud V, Gillibert Duplantier J, Mazzocco C, et al.. Thrombin upregulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, EGF receptor-independent, mechanism. J Biol Chem 2003; in press.
19. Streetz KL, Wustefeld T, Klein C, et al.. Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisyle-grand) 2001; 47: 661-73.
20. Nieto N, Dominguez-Rosales JA, Fontana L, et al.. Rat hepatic stellate cells contribute to the acute-phase response with increased expression of alpha1(I) and alpha1(IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAs. Hepatology 2001; 33: 597-607.
21. Iino M, Foster DC, Kisiel W. Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arterioscler Thromb Vasc Biol 1998; 18: 40-6.
22. Aldeguer X, Debonera F, Shaked A, et al.. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 2002; 35: 40-8.
23. Omori N, Evarts RP, Omori M, et al.. Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat. Lab Invest 1996; 75: 15-24.
24. Bustos M, Beraza N, Lasarte JJ, et al.. Protection against liver damage by car- diotrophin-1: A hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology 2003; 125: 192-201.
25. Miyagi Y, Koshikawa N, Yasumitsu H, et al.. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: Identification as placental protein 5 and tissue factor pathway inhibitor-2. J Biochem (Tokyo). 1994; 116: 939-42.
26. Izumi H, Takahashi C, Oh J, et al.. Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes. FEBS Lett 2000, 481: 31-6.
27. Crawley JT, Goulding DA, Ferreira V, et al.. Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 2002; 22: 218-24.
28. Kamei S, Petersen LC, Sprecher CA, et al.. Inhibitory properties of human recombinant Arg24→Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2). Tbromb Res 1999; 94: 147-52.
29. Hisaka T, Kisiel W, Rosenbaum J. cDNA cloning and tissue distribution of the rat ortholog of tissue factor pathway inhibitor-2. Thromb Haemost 2002; 88: 356-7.
30. Shimokawa T, Yamamoto K, Kojima T, et al.. Down-regulation of murine tissue factor pathway inhibitor mRSA by endotoxin and tumor necrosis factor-alpha In vitro and In vivo. Thromb Res 2000; 100: 211-21.
31. Enkhbaatar P, Okajima K, Murakami K, et al.. Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide- induced pulmonary vascular injury by inhibiting leukocyte activation. Am J Respir Crit Care Med 2000; 162: 1752-9.
32. Kazama Y, Kamei S, Kuijper JL, et al.. Nucleotide sequence of the gene encoding murine tissue factor pathway inhibitor-2. Thromb Haemost 2000; 83: 141-7.
33. Petit L, Lesnik P, Dachet C, et al.. The promoter of human tissue factor pathway inhibitor gene: Identification of potential regulatory elements. Thromb Res 1999; 95: 255-62.